Product Information
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Major Pharmaceuticals, priced at $0.1327 per EA under NDC 00904662361. Its NADAC has been published 470 times since Apr 26, 2017.
Strength
.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904662361
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA090509On Market Since
5/14/2010
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has been published 470 times since Apr 26, 2017, and over the history we have for it it has declined 49.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1327 per EA |
|---|---|
| All-time high | $0.6397 (Nov 11, 2020) |
| All-time low | $0.1091 (Nov 20, 2024) |
| 52-week high | $0.1744 |
| 52-week low | $0.1327 |
| Median price | $0.1898 |
| Average price | $0.2339 |
| Largest weekly change | +64.8% (Sep 23, 2020) |
| Weeks tracked | 470 |
| Tracking since | Apr 26, 2017 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Major Pharmaceuticals, is $0.1327 per EA (NDC 00904662361), effective Jun 24, 2026.
How has the price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has declined 49.2%. It has been tracked across 470 weekly CMS publications since Apr 26, 2017.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Apr 26, 2017, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1091 (Nov 20, 2024) to a high of $0.6397 (Nov 11, 2020), with a median of $0.1898 per EA.
Are there cheaper alternatives to TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
12 NADAC-published products share the same active ingredient, strength, and dosage form as TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 00904662361) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification